Yuan Sun

发表

Docking Study and Three-Dimensional Quantitative Structure- Activity Relationship （3D-QSAR） Analyses and Novel Molecular Design of a Series of 4-Aminoquinazolines as Inhibitors of Aurora B Kinase

Yadong Chen, Haopeng Sun, J. Zhu, 2011 .

Reasonably activating Nrf2: A long-term, effective and controllable strategy for neurodegenerative diseases.

Ying Chen, Q. Guo, Wenyuan Liu, 2019, European journal of medicinal chemistry.

Identification of 4-aminoquinoline core for the design of new cholinesterase inhibitors

Yuqiong Pei, Wei Li, Yaoyao Bian, 2016, PeerJ.

2,4-Dihydroxychalcone derivatives as novel potent cell division cycle 25B phosphatase inhibitors and protein tyrosine phosphatase 1B inhibitors.

Li-Ming Tang, Yuan Sun, C. Xie, 2014, Die Pharmazie.

Synthesis, cytotoxicity and topoisomerase II inhibitory activity of lomefloxacin derivatives.

Q. You, Haopeng Sun, Yuan Sun, 2013, Bioorganic & medicinal chemistry letters.

Identification by shape-based virtual screening and evaluation of new tyrosinase inhibitors

Haopeng Sun, Yuan Sun, Chen Kang, 2018, PeerJ.

Synthesis and Evaluation of Gambogic Acid Derivatives as Antitumor Agents. Part III

Q. You, Q. Guo, Cheng Jiang, 2013, Chemistry & biodiversity.

Development of Alectinib-Based PROTACs as Novel Potent Degraders of Anaplastic Lymphoma Kinase (ALK).

Zhe-Sheng Chen, Dong-Hua Yang, Shengtao Xu, 2021, Journal of medicinal chemistry.

Discovery of Norbornene as a Novel Hydrophobic Tag Applied in Protein Degradation.

Zhe-Sheng Chen, Dong-Hua Yang, Shengtao Xu, 2023, Angewandte Chemie.